- Valneva aquired Crucell Sweden and DUKORAL from J&J to complement their portfolio of traveler's vaccines
- The €45m fully underwritten rights issue allows for certainty of funds at time of signing
- Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner
The investment services and investment institutions mentioned on the website may not be available in your jurisdiction or to anyone other than professional investors. More information about the countries where these investment institutions are registered and the persons to whom they may be offered can be found on the website.